What is STERIS's R&D?

STERIS (STE) reported R&D of $28.8M in Q1 2026.

How has STERIS's R&D changed year-over-year?

STERIS's R&D increased by 4.3% year-over-year, from $27.6M to $28.8M.

What is the long-term trend for STERIS's R&D?

Over 4 years (2022 to 2026), STERIS's R&D has grown at a 6.8% compound annual growth rate (CAGR), from $86.66M to $112.9M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

STERIS STE R&D

R&D at other companies

Baxter InternationalBAX

$139M-0.7%

StrykerSYK

$413M+2.0%

IAR

Integra LifeSciencesIART

$23.5M-5.0%

FortiveFTV

$66.5M+3.9%

Intuitive SurgicalISRG

$361.9M+14.5%

CONMEDCNMD

$16.33M+26.2%

Segments

By segment

See full

Healthcare Segment$25.3M+6.8%

Life Sciences:$2.8M+16.7%

AST$800K-27.3%

Other financials

Income statement

See full

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

See full

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

See full

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation

See full

Market cap$20.52B-9.4%

Enterprise value$22.17B-8.8%

P/E26.2×-8.8×

P/S3.5×-0.6×

Profitability

See full

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

See full

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is STERIS's R&D?: STERIS (STE) reported R&D of $28.8M in Q1 2026.
How has STERIS's R&D changed year-over-year?: STERIS's R&D increased by 4.3% year-over-year, from $27.6M to $28.8M.
What is the long-term trend for STERIS's R&D?: Over 4 years (2022 to 2026), STERIS's R&D has grown at a 6.8% compound annual growth rate (CAGR), from $86.66M to $112.9M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.